次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

キナーゼ阻害剤:世界市場2026年予測

Kinase Inhibitors: Global Markets

出版元:BCC ResearchLinkIcon出版元について
発行年:2021年6月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文219ページになります。
商品コード:BCC268

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
キナーゼ阻害剤の世界市場規模は2021年で576億ドル、2026年には792億ドルに達すると予測されます。当レポートでは、キナーゼ阻害剤の市場/技術的背景、COVID-19の影響、規制シナリオ、各種セグメント別市場分析(タイプ別、用途別、国地域別)、業界動向、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
◆イントロダクション
・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術背景
・定義
・酵素阻害剤
・キナーゼ阻害剤
・市場ダイナミクス(ドライバー、障壁、機会)

◆COVID-19の影響
・COVID-19によるがん治療への影響

◆規制シナリオ
・キナーゼ阻害剤の市場リーダーとその製品

◆キナーゼ阻害剤市場、タイプ別
・チロシンキナーゼ阻害剤
・セリン/スレオニンキナーゼ阻害剤
※市場予測データ-2026年掲載

◆キナーゼ阻害剤、用途別
・抗腫瘍剤
・加齢性黄斑変性症(AMD)
・免疫抑制剤
※市場予測データ-2026年掲載

◆キナーゼ阻害剤、国地域別
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※市場予測データ-2026年掲載
※タイプ別、用途別のデータ掲載

◆業界動向
・企業シェア分析
・パイプライン分析
・特許分析
・現在のシナリオ
・癌およびキナーゼ阻害剤
・複数の単一キナーゼ阻害剤vs.単一のマルチキナーゼ阻害剤
・今後の動向

◆主要企業プロフィール
・ASTRAZENECA
・BAYER AG
・BOEHRINGER INGELHEIM INTERNATIONAL GMBH
・BRISTOL-MYERS SQUIBB
・エーザイ株式会社
・F. HOFFMANN-LA ROCHE LTD.
・JOHNSON & JOHNSON
・NOVARTIS AG
・PFIZER

(その他メーカー)
・アステラス製薬株式会社
・AVEO PHARMACEUTICALS, INC.
・EXELIXIS INC.
・MERCK KGAA
・SANOFI
・武田薬品工業株式会社

(全129頁)



【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Kinase Inhibitors: Global Markets

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Definitions

  • Enzymes
  • Coenzymes

Enzyme Inhibitors

  • Active Site
  • Enzyme Inhibitors
  • Why Enzyme Inhibition?
  • Use of Enzyme Inhibitors
  • Mechanism of Enzyme Inhibition
  • Types of Enzyme Inhibitors
  • Classification of Enzyme Inhibitors

Kinase Inhibitors

  • History of Protein Kinases
  • Type of Kinase Inhibitors
  • Classification by Types of Amino Acid Phosphorylation
  • Classification by Site of Action

Market Dynamics

  • Drivers
  • Market Restraints
  • Opportunity

Chapter 4 Covid Impact on Market

Overview

  • Short-Term Impact on Pharmaceutical Industry
  • Long-Term Impact
  • Current Outlook

COVID-19 Impact on Cancer Care

Chapter 5 Regulatory Scenario

Overview
Market Leaders and Their Products for Kinase Inhibitors

Chapter 6 Market Breakdown by Type

Introduction
Tyrosine Kinase Inhibitors

  • Market Size and Forecast
  • Market Analysis

Serine/Threonine Kinase Inhibitors

  • mTOR Kinase Inhibitors
  • B-Raf
  • RHO Kinase Inhibitors
  • Cyclin-Dependent Kinase Inhibitors
  • Aurora Kinase Inhibitors
  • MAP/MEK Kinase Inhibitors
  • JNK Inhibitors
  • Protein Kinase C Inhibitors
  • PI3K Inhibitors
  • Market Size and Forecast
  • Market Analysis

Chapter 7 Market Breakdown by Application

Introduction
Antineoplastic Agents

  • Market Size and Forecast
  • Market Analysis

Age-related Macular Degeneration (AMD)

  • Market Size and Forecast
  • Market Analysis

Immunosuppressant

  • Market Size and Forecast
  • Market Analysis

Chapter 8 Market Breakdown by Region

Introduction
North America

  • Market Analysis
  • U.S.
  • Canada

Europe

  • Market Analysis
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • Market Analysis
  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Market Size and Forecast
  • Market Analysis

Chapter 9 Industry Developments

Company Share Analysis
Pipeline Analysis
Patent Analysis
Current Scenario
Cancer and Kinase Inhibitors
Multiple Single Kinase Inhibitors Vs. Single Multikinase Inhibitors

  • Efficacy
  • Resistance
  • Pharmacokinetics
  • Selectivity
  • Tumor Microenvironment
  • Toxicity

Future Directions

Chapter 10 Company Profiles

Leading Companies
ASTRAZENECA
BAYER AG
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB
EISAI CO. LTD.
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON
NOVARTIS AG
PFIZER
Other Manufacturers
ASTELLAS PHARMA INC.
AVEO PHARMACEUTICALS, INC.
EXELIXIS INC.
MERCK KGAA
SANOFI
TAKEDA PHARMACEUTICAL CO., LTD.
Chapter 11 Appendix A: Abbreviations and Acronyms

List of Tables

Summary Table A : Global Market for Kinase Inhibitors, by Type, Through 2026
Summary Table B : Global Market for Tyrosine Kinase Inhibitors, by Type, Through 2026
Table 1 : Classification of Enzyme Inhibitors
Table 2 : History of Protein Kinases
Table 3 : ATP-Competitive and Non-Competitive Inhibitors
Table 4 : Types of Serine/Threonine Kinase Inhibitors
Table 5 : Types of Receptor Tyrosine Kinase Inhibitors
Table 6 : Types of Non-Receptor Tyrosine Kinase Inhibitors
Table 7 : Classification of Kinase Inhibitors by Site of Action
Table 8 : Patent Expiration Dates of Kinase Inhibitors
Table 9 : Coronavirus Reported Cases and Deaths, by Country, May 2021
Table 10 : FDA-Approved Kinase Inhibitors, 2001-2021
Table 11 : FDA-approved Kinase Inhibitors and Their Drug Targets
Table 12 : EMA-approved Kinase Inhibitors, 2001-2020
Table 13 : Safety Alerts and Warnings for Kinase Inhibitors
Table 14 : Leading Manufacturers and Suppliers of Receptor Tyrosine Kinase Inhibitors
Table 15 : Leading Manufacturers and Suppliers of Non-Receptor Tyrosine Kinase Inhibitors
Table 16 : Leading Manufacturers and Suppliers of Serine/Threonine Tyrosine Kinase Inhibitors
Table 17 : Global Market for Kinase Inhibitors, by Type, Through 2026
Table 18 : Global Market for Tyrosine Kinase Inhibitors, by Region, Through 2026
Table 19 : Global Market for Tyrosine Kinase Inhibitors, by Type, Through 2026
Table 20 : Global Market for Serine/Threonine Kinase Inhibitors, by Region, Through 2026
Table 21 : Global Market for Kinase Inhibitors, by Application, Through 2026
Table 22 : Global Market for Kinase Inhibitors Used as Antineoplastic Agents, by Region, Through 2026
Table 23 : Global Market for Kinase Inhibitors Used in Age-related Macular Degeneration, by Region, Through 2026
Table 24 : Global Market for Kinase Inhibitors Used as Immunosuppressants, by Region, Through 2026
Table 25 : Global Market for Kinase Inhibitors, by Region, Through 2026
Table 26 : North American Market for Kinase Inhibitors, by Type, Through 2026
Table 27 : North American Market for Tyrosine Kinase Inhibitor, by Type, Through 2026
Table 28 : North American Market for Kinase Inhibitors, by Application, Through 2026
Table 29 : North American Market for Kinase Inhibitors, by Country, Through 2026
Table 30 : European Market for Kinase Inhibitors, by Type, Through 2026
Table 31 : European Market for Tyrosine Kinase Inhibitor, by Type, Through 2026
Table 32 : European Market for Kinase Inhibitors, by Application, Through 2026
Table 33 : European Market for Kinase Inhibitors, by Country, Through 2026
Table 34 : Asia-Pacific Market for Kinase Inhibitors, by Type, Through 2026
Table 35 : Asia-Pacific Market for Tyrosine Kinase Inhibitor, by Type, Through 2026
Table 36 : Asia-Pacific Market for Kinase Inhibitors, by Application, Through 2026
Table 37 : Asia-Pacific Market for Kinase Inhibitors, by Country, Through 2026
Table 38 : ROW Market for Kinase Inhibitors, by Type, Through 2026
Table 39 : ROW Market for Tyrosine Kinase Inhibitor, by Type, Through 2026
Table 40 : ROW Market for Kinase Inhibitors, by Application, Through 2026
Table 41 : Revenue from Kinase Inhibitors, 2019-2020
Table 42 : Ongoing Clinical Trials of Various Kinase Inhibitors
Table 43 : Patents Filed for Kinase Inhibitors
Table 44 : AstraZeneca: Kinase Inhibitors Drugs Product Portfolio
Table 45 : Bayer AG: Kinase Inhibitors Drugs Product Portfolio
Table 46 : Boehringer Ingelheim: Kinase Inhibitors Drugs Product Portfolio
Table 47 : Bristol-Myers Squibb: Kinase Inhibitors Drugs Product Portfolio
Table 48 : Eisai Co.: Kinase Inhibitors Drugs Product Portfolio
Table 49 : F. Hoffmann-La Roche: Kinase Inhibitor Drugs Product Portfolio
Table 50 : Johnson & Johnson: Kinase Inhibitors Drugs Product Portfolio
Table 51 : Novartis AG: Kinase Inhibitor Drugs Product Portfolio
Table 52 : Pfizer: Kinase Inhibitor Drugs Product Portfolio
Table 53 : Abbreviations Used in This Report

List of Figures

Summary Figure A : Global Market Shares of Kinase Inhibitors, by Application, 2020
Summary Figure B : Global Market for Kinase Inhibitors, by Region, 2019-2026
Figure 1 : Estimated Numbers of New Cancer Cases in Women, 2020
Figure 2 : Estimated Numbers of New Cancer Cases in Men, 2020
Figure 3 : National Cancer Institute Research Funding, 2012-2019
Figure 4 : Impact of COVID-19 on Pharmaceutical Industry
Figure 5 : Global Market Shares of Kinase Inhibitors, by Type, 2020
Figure 6 : Global Market for Tyrosine Kinase Inhibitors, 2020-2026
Figure 7 : Global Market for Tyrosine Kinase Inhibitors, by Region, 2019-2026
Figure 8 : Global Market Shares of Tyrosine Kinase Inhibitors, by Type, 2020
Figure 9 : Global Market for Serine/Threonine Kinase Inhibitors, 2020-2026
Figure 10 : Global Market for Serine/Threonine Kinase Inhibitors, by Region, 2019-2026
Figure 11 : Global Market Shares of Kinase Inhibitors, by Application, 2020
Figure 12 : Global Market for Kinase Inhibitors Used as Antineoplastic Agents, 2020-2026
Figure 13 : Global Market for Kinase Inhibitors Used as Antineoplastic Agents, by Region, 2019-2026
Figure 14 : Global Market for Kinase Inhibitors Used in Age-related Macular Degeneration, 2020-2026
Figure 15 : Global Market for Kinase Inhibitors Used in Age-related Macular Degeneration, by Region, 2019-2026
Figure 16 : Global Market for Kinase Inhibitors Used as Immunosuppressants, 2020-2026
Figure 17 : Global Market for Kinase Inhibitors Used as Immunosuppressants, by Region, 2019-2026
Figure 18 : Global Market Shares of Kinase Inhibitors, by Region, 2020
Figure 19 : North American Market Shares of Kinase Inhibitors, by Type, 2020
Figure 20 : North American Market Shares of Kinase Inhibitors, by Application, 2020
Figure 21 : North American Market Shares of Kinase Inhibitors, by Country, 2020
Figure 22 : U.S. Market for Kinase Inhibitors, 2020-2026
Figure 23 : Canadian Market for Kinase Inhibitors, 2020-2026
Figure 24 : European Market Shares of Kinase Inhibitors, by Type, 2020
Figure 25 : European Market Shares of Kinase Inhibitors, by Application, 2020
Figure 26 : European Market Shares of Kinase Inhibitors, by Country, 2020
Figure 27 : German Market for Kinase Inhibitors, 2020-2026
Figure 28 : U.K. Market for Kinase Inhibitors, 2020-2026
Figure 29 : French Market for Kinase Inhibitors, 2020-2026
Figure 30 : Italian Market for Kinase Inhibitors, 2020-2026
Figure 31 : Spanish Market for Kinase Inhibitors, 2020-2026
Figure 32 : Rest of Europe Market for Kinase Inhibitors, 2020-2026
Figure 33 : Asia-Pacific Market Shares of Kinase Inhibitors, by Type, 2020
Figure 34 : Asia-Pacific Market Shares of Kinase Inhibitors, by Application, 2020
Figure 35 : Asia-Pacific Market Shares of Kinase Inhibitors, by Country, 2020
Figure 36 : Chinese Market for Kinase Inhibitors, 2020-2026
Figure 37 : Japanese Market for Kinase Inhibitors, 2020-2026
Figure 38 : Indian Market for Kinase Inhibitors, 2020-2026
Figure 39 : Rest of Asia-Pacific Market for Kinase Inhibitors, 2020-2026
Figure 40 : ROW Market Shares of Kinase Inhibitors, by Type, 2020
Figure 41 : ROW Market Shares of Kinase Inhibitors, by Application, 2020
Figure 42 : Global Market Share Analysis of Kinase Inhibitor, by Company, 2020
Figure 43 : Clinical Trial Phases of Various Kinase Inhibitors, 2020
Figure 44 : AstraZeneca: Annual Revenue, 2017-2020
Figure 45 : Bayer AG: Annual Revenue, 2017-2020
Figure 46 : Boehringer Ingelheim: Annual Revenue, 2017-2020
Figure 47 : Bristol-Myers Squibb: Annual Revenue, 2017-2020
Figure 48 : Eisai Co. Ltd.: Annual Revenue, 2017-2019
Figure 49 : F. Hoffmann-La Roche: Annual Revenue, 2017-2020
Figure 50 : Johnson & Johnson: Annual Revenue, 2017-2020
Figure 51 : Novartis AG: Financial Performance, 2017-2020
Figure 52 : Pfizer: Annual Revenue,2017-2020



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。